Top

International Journal of Clinical Oncology

Published in:

01-06-2006 | REVIEW ARTICLE

Biological and clinical implications of EGFR mutations in lung cancer

Authors: Tetsuya Mitsudomi, Takayuki Kosaka, Yasushi Yatabe

Published in: International Journal of Clinical Oncology | Issue 3/2006

Title: Biological and clinical implications of EGFR mutations in lung cancer
Authors: Tetsuya Mitsudomi
Takayuki Kosaka
Yasushi Yatabe
Publication date: 01-06-2006
Publisher: Springer-Verlag
Published in: International Journal of Clinical Oncology / Issue 3/2006
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-006-0583-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

ACC 2024 Congress

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2006

Molecular targeting therapy for renal cell carcinoma

Cholangiocellular carcinoma that produced both granulocyte-colony-stimulating factor and parathyroid hormone-related protein

Methodological aspects of current problems in target-based anticancer drug development

Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer

Management of sentinel lymph nodes in malignant skin tumors using dynamic lymphoscintigraphy and the single-photon-emission computed tomography/computed tomography combined system

Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib

Keynote webinar | Spotlight on antibody–drug conjugates in cancer